Related Experiment Video

Updated: Sep 21, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Childhood polymyositis/dermatomyositis

L J Roberts1, C W Fink

  • 1Department of Dermatology, University of Texas Health Science Center at Dallas/Southwestern Medical School.

Clinics in Dermatology
|April 1, 1988
PubMed

Insights

Pediatric inflammatory myopathies, Polymyositis/Dermatomyositis (PM/DM), present unique features like vasculopathy. While the exact cause is unknown, immune responses and potential viral triggers are implicated in muscle and endothelial cell damage.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Vascular Biology

Background:

  • Pediatric inflammatory myopathies, including Polymyositis/Dermatomyositis (PM/DM), exhibit distinct clinical and pathological characteristics compared to adult forms.
  • A significant distinguishing feature in children is the prevalence of widespread vasculopathy, affecting blood vessels throughout the body.

Purpose of the Study:

  • To highlight the unique aspects of pediatric PM/DM, focusing on the prominent vasculopathy.
  • To review current understanding and proposed mechanisms of disease pathogenesis in children with PM/DM.

Main Methods:

  • Literature review and synthesis of existing research on pediatric PM/DM.
  • Analysis of characteristic pathological findings, particularly vasculopathy.
  • Discussion of proposed immunological and etiological factors.

Main Results:

  • Pediatric PM/DM is characterized by extensive vasculopathy, differentiating it from adult presentations.
  • Both humoral and cell-mediated immune responses are implicated in the disease process.
  • Evidence suggests a potential role for viral agents in triggering immune-mediated damage to muscles and endothelial cells.

Conclusions:

  • The pathogenesis of pediatric PM/DM remains incompletely understood, necessitating further investigation.
  • Understanding the role of vasculopathy and potential infectious triggers is crucial for future research and therapeutic strategies.

More Related Videos

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...